# Cellphire awarded $29.25M U.S. Army contract for cryopreserved platelet development

Cellphire Inc. was awarded a 6.5-year contract valued at $29.25 million by the U.S. Army Medical Research Acquisition Activity to develop an FDA-licensed cryopreserved platelet product.

- Type: Contract
- Announced: 2020-01-15
- Where: United States
- Value: $29.3M
- Status: announced
- Products: cryopreserved platelets
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Cellphire](https://endata.com/companies/44556.md)
- [U.S. Army Medical Research Acquisition Activity](https://endata.com/companies/44557.md) (customer)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/cellphire-awarded-29-25-million-us-army-cryopreserved-platelet-development-contract-300987022.html), 2020-01-15: "Cellphire is pleased that USAMRAA has awarded us with this important contract."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.